SCHEMBL29631858

SCHEMBL29631858

COC(=O)c1cc(Cn2c(=O)c3c(nc(Br)n3C)n(C)c2=O)ccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.52
▸ HIF1A Q16665 3/20 0.52
▸ HPGD P15428 3/20 0.52
▸ MAPT P10636 5/20 0.51
▸ TSHR P16473 3/20 0.51
▸ POLB P06746 3/20 0.51
▸ TP53 P04637 1/20 0.51
▸ MTHFD2 P13995 1/20 0.51
▸ KMT2A Q03164 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ CYP2C9 P11712 3/20 0.50
▸ CYP2C19 P33261 3/20 0.50
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ LMNA P02545 3/20 0.49
▸ STAT6 P42226 1/20 0.49
▸ NPSR1 Q6W5P4 3/20 0.48
▸ HTT P42858 1/20 0.48
▸ PKM P14618 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ CYP1A2 P05177 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18989621 1.00 ALDH1A1 (0.52) ALDH1A1HIF1AHPGDMAPTTSHR
SCHEMBL18989627 0.84 SMN1; SMN2 (0.66) ALDH1A1HIF1AHPGDMAPTTSHR
SCHEMBL18990018 0.84 ALDH1A1 (0.55) ALDH1A1HIF1AHPGDMAPTTSHR
SCHEMBL18989866 0.83 MAPK1 (0.56) TSHRMTHFD2KMT2ASMN1; SMN2LMNA
SCHEMBL18990414 0.83 TP53 (0.68) ALDH1A1HIF1AHPGDMAPTTSHR
SCHEMBL18990073 0.81 ALDH1A1 (0.57) ALDH1A1HIF1AHPGDMAPTTSHR
SCHEMBL18989821 0.81 MAPT (0.61) ALDH1A1HIF1AHPGDMAPTTSHR
SCHEMBL18989851 0.80 SMN1; SMN2 (0.68) ALDH1A1HIF1AHPGDMAPTTSHR
SCHEMBL18990320 0.80 LMNA (0.65) ALDH1A1HIF1AHPGDMAPTTSHR
SCHEMBL18990047 0.79 MAOB (0.55) ALDH1A1HIF1AHPGDMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12187728-B2 Caffeine inhibitors of MTHFD2 and uses thereof RAZE THERAPEUTICS, INC. (US) 2025-01-07 — — US disclosed
US-20230067237-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF RAZE THERAPEUTICS, INC. 2023-03-02 — — US disclosed
US-11370792-B2 Caffeine inhibitors of MTHFD2 and uses thereof RAZE THERAPEUTICS, INC. (US) 2022-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12187728-B2 Caffeine inhibitors of MTHFD2 and uses thereof MTHFD2, MTHFD1, NUDT15 ALDH1A1 260/4885HIF1A 2295/4885HPGD 188/4885
US-11370792-B2 Caffeine inhibitors of MTHFD2 and uses thereof MTHFD2, MTHFD1, NUDT15 ALDH1A1 260/4885HIF1A 2295/4885HPGD 188/4885
US-20230067237-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF MTHFD2, MTHFD1, NUDT15 ALDH1A1 260/4885HIF1A 2295/4885HPGD 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback